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A B S T R A C T
Objective: To demonstrate the burden of Haemophilus inﬂuenzae type b (Hib) disease in Sri Lanka and
provide information for decision-making in public health planning and vaccine introduction.
Methods: This was a prospective, population-based study carried out in 2004, to describe the
epidemiology and calculate the incidence of meningitis caused by Hib in children <5 years of age in the
district of Colombo, Sri Lanka. Hib was identiﬁed in cerebrospinal ﬂuid (CSF) specimens by culture and
antigen detection (latex agglutination test; LAT).
Results: The lumbar puncture rate in children <5 years of age was 1.9%. A causative bacterial organism
was identiﬁed in 108meningitis cases, and in 54 (50%) this was Hib. The LAT increased the Hib detection
rate in CSF four-fold. In 2004, the annual incidence of Hib meningitis in Colombo was 20.1 cases per
100 000 children aged <5 years.
Conclusions: This study is the ﬁrst from Sri Lanka reporting theHibmeningitis incidence rate pre-vaccine
introduction. The reported incidence rate is one of the highest from the Asian region, but is likely an
underestimation considering the difﬁculties in the laboratory identiﬁcation of Hib.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Haemophilus inﬂuenzae type b (Hib) is considered to be themost
common cause of bacterial meningitis and one of the most
common causes of invasive infections among young children
worldwide, except in countries where Hib conjugate vaccines have
been introduced into the routine immunization program.1,2 Safe,
effective Hib conjugate vaccines have been available for use in
national immunization schedules over the last two decades,
however their uptake by developing countries has been minimal
due to the initial high cost of the vaccines as well as the non-
availability of local disease burden data. Those countries that have
introduced Hib conjugate vaccines over the last two decades,
mainly developed countries and more recently a few developing
countries, have effectively reduced Hib diseasemorbidity and have
almost eliminated Hib disease mortality.§ Presented in part at the Meningitis Research Foundation Conference, London,
UK, November 23–24, 2005 as poster E1, entitled ‘‘Epidemiology of Hib infections in
the district of Colombo, Sri Lanka’’.
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doi:10.1016/j.ijid.2009.06.018Sri Lanka has an impressive public health record and has
maintained very high childhood immunization coverage. Themost
recently introduced vaccine was the hepatitis B vaccine in 2003.
The lack of data on Hib disease burden in Sri Lanka has led to the
perception that Hib infection is not important in this country. To
provide appropriate evidence for decision-making with regard to
the introduction of the Hib conjugate vaccine into the Expanded
Programme on Immunization (EPI) in Sri Lanka, we conducted this
study to determine childhood Hib meningitis incidence in the
district of Colombo.
2. Materials and methods
2.1. Study site and study population
This prospective population-based study of childhood bacterial
meningitis was conducted in the district of Colombo. Colombo has
the best child-to-pediatrician ratio in the country and parents have
high health-seeking behavior. The population of the district of
Colombo is stable, and close to 50% of this population lives in an
urban environment. In 2004, the district’s estimated mid-year
population of children aged <5 years was 179 103.3ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Distribution of admissions and lumbar puncture data for children aged <5 years in the ﬁve study hospitals; January–December 2004
Outcome Study hospital Total
LRH CSTH SJGH HBH ABH
All cause pediatric admissions 63944 14583 3447 5440 6409 93823
Admissions at <5 years of age 40924 9480 2098 3678 4334 60514
Lumbar punctures at <5 years of age 826 146 48 47 79 1146
Lumbar puncture rate (%) in admissions
of those aged <5 years
2.0 1.5 2.3 1.3 1.8 1.9
LRH, Lady Ridgeway Hospital; CSTH, Colombo South Teaching Hospital; SJGH, Sri Jayawardenapura General Hospital; HBH, Homagama Base Hospital; ABH, Avissawella Base
Hospital.
Table 2
Demographic characteristics of patients with meningitis
Characteristic Probable bacterial
meningitis patients
(N=333)
Hib meningitis
patients (N=54)
%
Total 333 54 100
Age group (months)
0–2 32 4 7
3–11 170 28 52
12–23 45 10 19
24–35 25 3 6
36–47 27 3 6
48–59 34 6 11
Sex
Male 207 32 59
Female 126 22 41
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disease in the district of Colombo participated in this study. Of
these, the Lady Ridgeway Hospital (LRH) for Children is a 750-bed
teaching hospital. LRH is the national pediatric referral hospital
with six pediatric units. Two other hospitals were national level
teaching hospitals and two were district level hospitals where
specialist services are available. Thus all the pediatric inpatient
units in the district participated in the study; all used standard
clinical and laboratory protocols. It is unlikely that any Hib
meningitis cases from the district were treated outside the units
participating in the study.
2.2. Inclusion and exclusion criteria
All children aged<5 years admitted to the study hospitals were
screened for signs and symptoms of bacterial meningitis. Case
deﬁnitions described by theWorld Health Organization (WHO) for
Hib surveillance were used.4 All clinicians in participating
hospitals used the same inclusion criteria, exclusion criteria and
standard case deﬁnitions. Children aged <5 years admitted to the
study hospitals with suspected bacterial meningitis from the
district of Colombo were recruited into the study. Children from
outside the district of Colombowere also offered the same services
but were excluded from calculations. Lumbar punctures were
routinely performed to evaluate all suspected meningitis patients,
as is the standard practice in Sri Lanka.
2.3. Case deﬁnitions
A probable bacterial meningitis case was deﬁned according to
the WHO generic protocol5 for population-based surveillance of
Hib as: a child<5 years of age presentingwith clinical symptoms of
meningitis (fever, headache, stiff neck, bulging fontanel (in
infants), or changes in mental status) whose cerebrospinal ﬂuid
(CSF) has at least one of the following features: (1) turbid
appearance, (2) elevated protein >100 mg/dl, (3) decreased
glucose <40 mg/dl, and (4) leukocytosis >100  106 white blood
cells/l with >80% neutrophils.
2.4. Laboratory methods
The present study implemented standard operating laboratory
procedures based on routinemicrobiological procedures andWHO
recommendations. The routine practice of using culturemedia was
modiﬁed to optimize isolation rates of H. inﬂuenzae. CSF was
cultured for Hib on chocolate agar plates (Oxoid, Cambridge, UK)
supplemented with X and V factors and incubated at 37 8C in 5–
10% carbon dioxide.4 For the identiﬁcation of bacteria other than
Hib, CSF was simultaneously cultured on blood agar and
MacConkey agar and brain–heart infusion medium. Typing of H.
inﬂuenzae strains was carried out at the Medical Research Institute
in Colombo using standard sera. A latex agglutination test (LAT)
was used for the diagnosis of Hib (Wellcogen, Remel Inc., USA). The
LAT also detected group B Streptococcus, Streptococcus pneumo-niae, Neisseria meningitidis ACY W135, and Escherichia coli K1/N.
meningitidis B in addition to Hib. Bacterial cultures and LAT were
performed on all CSF samples. Patients with culture-positive and/
or LAT-positive CSF samples were classiﬁed as conﬁrmed bacterial
meningitis cases.
The latex test was made available to all practicing consultant
pediatricians in the district including the private sector. Pediatric
admissions to adjoining district hospitals were scrutinized to
detect any cases from the district of Colombo. Pediatric deaths
within 24 h reported to the judicial medical ofﬁces in the district
and district death registers were also scrutinized to detect possible
pediatric deaths occurring before hospital admission.
3. Results
3.1. Study subjects
From January 1 to December 31, 2004 a total of 60 514 children
aged <5 years were admitted to the study hospitals. A lumbar
puncture was done for 1146 of these children who were suspected
of having meningitis (Table 1). The overall lumbar puncture rate in
those admitted at <5 years of age was 1.9%.
During the study period, consultant pediatricians in the private
sector did not report any Hib cases and the adjoining district
hospitals did not admit any suspected meningitis cases from the
district of Colombo. The pediatric deaths review for the district of
Colombo revealed only accidental deaths in those under 5 years of
age during the study period.
Of the enrolled patients, males outnumbered females at a ratio
of 3:2 and 60% of the children in the age group 0–5 years who
underwent a lumbar puncture were male (Table 2). There were
three children<5 years of age whowere admittedwith a diagnosis
of suspected bacterial meningitis who died within 24 h of
admission to the study hospitals. All three cases were included
in the study and their CSF samples were tested by both culture and
LAT.
Figure 1. Age distribution of 54Haemophilus inﬂuenzae type b (Hib)meningitis cases.
Table 4
Comparison of identiﬁcation of organisms in CSF by culture and LAT
Organism LAT
only
LAT and
culture
Culture
only
Total positives
n %
Haemophilus inﬂuenzae
type b
42 11 1 54 50
Group B Streptococcus 23 2 0 25 23
Streptococcus pneumoniae 8 6 0 14 13
Neisseria meningitidis 8 0 0 8 7
Escherichia coli 1 0 4 5 5
Group D Streptococcusa - - 2 2 2
Total 82 19 7 108 100
CSF, cerebrospinal ﬂuid; LAT, latex agglutination test.
a The LAT does not contain group D Streptococcus sera.
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Sixty percent of all Hibmeningitis cases were aged<12months
(Figure 1). Almost 80% of the Hib meningitis cases were <24
months of age. Thirty-two Hib cases occurred in those aged <12
months: four (7%) cases occurred at <2 months of age, 16 (30%)
cases occurred in those between 3 and 6 months of age, and 12
(22%) were cases aged between 6 and 11 months.
Hib accounted for 16% of the probable bacterial meningitis
cases and 50% of the microbiologically conﬁrmed bacterial
meningitis cases in children under 5 years of age.
3.3. Clinical characteristics of meningitis patients
Ill appearance of the child, drowsiness, irritability and poor
sucking or refusal of feed were the leading clinical features and
were present in more than 50% of all meningitis patients (Table 3).
Meningitis patients had signiﬁcantly longer duration of hospital
stay compared to non-meningitis patients (Chi-square = 36.4,
degrees of freedom (df) = 2, p< 0.001), but there was no difference
between Hib meningitis patients and other meningitis patients
(Chi-square = 0.176, df = 2, p = 0.41). Only 40% of Hib meningitis
patients went home within 14 days compared to 51% of other
meningitis patients. There were seven deaths among other
meningitis patients (n = 279), but none of the conﬁrmed Hib
meningitis patients died. Well established pediatric tertiary care
facilities and well distributed primary care within the district may
be possible reasons for not recordingmortality amongHib patients
during the study year.Table 3
Description of clinical features among 1146 patients who had a lumbar puncture
Clinical features Hib meningitisa
n %
Total 54 100
Ill appearance of the child 51 94
Drowsiness 34 63
Irritability 33 61
Poor sucking/off feeds 30 56
Vomiting 29 54
Seizures 20 37
Neck stiffness 12 22
Kernig’s sign 10 19
Rash 2 4
Infants <12 months, n 32
Bulging fontanel, n (%) 6 (19)
a Hib meningitis: Hib detected by culture or latex.
b Other meningitis: other cases of meningitis.
c Non-meningitis: patients who were suspected of meningitis and had a lumbar pun3.4. Laboratory results
Of the 1146 CSF specimens, 333 samples were suggestive of
meningitis based on microscopy and biochemistry and were
diagnosed as ‘probable bacterial meningitis’ cases (Table 2). In the
remaining children (n = 813) who had a lumbar puncture,
meningitis was excluded based on the laboratory criteria, and
the average meningitis conﬁrmation rate following lumbar
puncture was 29%.
An organismwas identiﬁed either by culture and/or by LAT in 108
of the333probablebacterialmeningitis cases. Theaverage laboratory
microbiological conﬁrmation and identiﬁcation of a bacterial
meningitis casewas 32%. Table 4 shows the identiﬁcation of infection
duetomicroorganismsbycultureandLAT. In the108meningitiscases
that were microbiologically conﬁrmed, 54 (50%) cases were
conﬁrmed as meningitis due to Hib. There were 12 H. inﬂuenzae
culture-positive isolatesandall12 isolateswereconﬁrmedasHib.The
second most common microorganism identiﬁed was group B
Streptococcus, which was detected in the CSF specimens of 25
patients, accounting for 23% of the conﬁrmed bacterial meningitis
cases. Of these 25 cases, 23 were detected by LAT and two by both
culture and LAT. S. pneumoniae was the third most common
microorganism (14 cases) and accounted for 13% of the conﬁrmed
bacterialmeningitis cases. Of these 14 cases, sixwerepositive byboth
culture and LAT and the balance positive only by LAT.
Overall, culture diagnosed only 22% of the Hib infections.
Additional use of LAT identiﬁed 42 patients who were culture-
negative and increased the overall detection of Hib meningitis
patients by 400%.Other meningitisb Non-meningitisc
n % n %
279 100 813 100
263 94 691 85
206 74 493 61
217 78 563 69
204 73 541 67
128 46 306 38
108 39 232 29
40 14 39 5
23 8 21 3
9 3 30 4
91 534
28 (31) 35 (7)
cture.
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Among the 333 probable bacterial meningitis cases, 162 (48%)
patients were residents of the district of Colombo. Of these, 80
(49%) had a bacterial organism identiﬁed out of which 36 were
laboratory-conﬁrmed as Hib. These 36 Hib meningitis cases from
the district of Colombo were used in the calculation of the Hib
meningitis incidence rate for the district of Colombo. The all-cause
meningitis incidence rate in the district of Colombo for the year
2004 was 90.5 cases per 100 000 children <5 years of age (95%
conﬁdence interval (CI) 77.6–105.6). The incidence of Hib
meningitis in the district of Colombo in 2004 was 20.1 cases per
100 000 children <5 years of age (95% CI 14.5–27.8).
4. Discussion
This is the ﬁrst study carried out in Sri Lanka reporting Hib
meningitis incidence. The incidence rate was 20.1 Hib meningitis
cases per 100 000 children<5 years of age in 2004 in the district of
Colombo, Sri Lanka. H. inﬂuenzae type b was the leading cause of
childhood meningitis, and the causative agent in 50% of the
bacterial meningitis cases where a microorganism was identiﬁed.
Our study has some limitations. There is a possibility that very
severe Hib cases die before being admitted to a hospital or start
treatment and investigation. Milder Hib cases may also be treated
in the outpatient department or by a family physician. Similarly
some patients may seek private medical services, even though this
is not a very common practice in Sri Lanka for severe childhood
illnesses. Further, some cases may be missed due to the low
isolation rate of Hib by culture despite the increased detection by
use of LAT. All these factors indicate that the incidence estimate
probably is an underestimate.
The Lombok Island vaccine probe study6 from Indonesia
reported an incidence rate of seven Hib meningitis cases per
100 000 children aged <5 years. The Hib study carried out by the
Thailand Ministry of Health7 in 2000 used a similar population-
based prospective methodology using LAT and can be conﬁdently
compared with the present study; it reported 3.64 Hib meningitis
cases per 100 000 in the population aged <5 years. Two studies
from India8,9 and another study from Bangladesh10 on Hib disease
do not report incidence data. However the diversity of methodol-
ogies of studies carried out in Asia does not warrant comparison.
The Hib meningitis incidence rate of 20.1 per 100 000
population aged <5 years reported in the present study is the
highest reported from the WHO South East Asian region.11 When
the highest reported annual Hibmeningitis incidence rates from all
WHO regions are compared, the present rate is lower only than the
rate in the African region (32.0 cases per 100 000 aged <5 years).
Nearly 60% of Hib meningitis (Table 2) occurred in infancy. This
percentage is similar to those reported by Peltola12 in 1999 for
Asian countries. The present study also showed a preponderance of
males. Similar ﬁndings were reported by Peltola13 in 1998. Fifty
percent of the conﬁrmed bacterial meningitis was due to Hib,
followed by group B Streptococcus, S. pneumoniae and N.
meningitidis. This is similar to the patterns reported by Peltola
in 1998.
India reports an incidence rate of 8.9 cases per 100 000 aged<5
years based on hospital data.14 A prospective population-based
study carried out from 2000 to 2001 in Thailand estimated a Hib
meningitis annual incidence rate of 3.64 per 100 000 aged<5 years
(95% CI 0.99–9.33).7 The district of Colombo has a geographically
well-deﬁned and stable population. The estimated mid-year
population of children aged 0–5 years in the district of Colombo
(179 103) fulﬁls the basic requirement of a Hib disease surveillance
population recommended by the WHO, which endorses a
minimum of 50 000–100 000 population <5 years.5 As elsewhere,Hibmeningitis in Asia mostly affects children under 2 years of age.
Almost 80% of Hib disease in the present study was in those aged
less than 23 months. The highest proportion (19%) of all Hib
infections was in the age group of 3 to 5 months. Peltola’s 1998
report for South East Asia showed 50–60% of Hib meningitis cases
occurring in the ﬁrst 5 months of life, contrasting with the present
study, which shows only 33% of all Hib meningitis cases in this age
group. The Sri Lankan pattern illustrates the need for an
intervention early in infancy. The timing of the DPT + HepB
(diphtheria–pertussis–tetanus + hepatitis B vaccine) at 2, 4 and 6
months in the current immunization schedule of Sri Lanka ﬁts well
with the epidemiology of Hib infection for an appropriate Hib
vaccine schedule for the country, especially for meningitis
observed in the present study.
Culturemethods identiﬁed only 12 Hibmeningitis cases and 26
of any microorganism, giving an isolation rate of 2% from 1146 CSF
cultures. This CSF culture detection rate for any microorganism is
low. Factors that may contribute to this may be the fastidious
nature of H. inﬂuenzae coupled with suboptimal microbiology
laboratory facilities and the use of antibiotics prior to admission.
On inquiry, 15% of the parents reported use of antibiotics for the
present illness prior to admission to the hospital. Further it is of
note that the use of LAT signiﬁcantly improved our diagnostic
ability, resulting in a four-fold higher Hib identiﬁcation rate.
The Hib meningitis incidence rate detected in the present study
is similar to the incidence rates reported from a large number of
industrialized countries prior to the widespread use of Hib
vaccines. Although there were no detected deaths due to H.
inﬂuenzae during the study period, the potential for the reduction
of Hib disease burden, morbidity, and suffering in Sri Lanka with
available effective immunization cannot be underestimated.
Although Hib vaccine is considered a cost-effective public
health investment, its high cost may be prohibitive when
introduced into low income countries such as Sri Lanka. The
Epidemiology Unit of the Sri Lanka Ministry of Health has
estimated that the introduction of Hib vaccine will increase Sri
Lanka’s annual vaccine cost by 55% and create a 32% gap in secure
funds for the EPI.15 Sri Lanka’s extensive primary healthcare
delivery network is a resilient system and is well suited to the
introduction of a new vaccine with minimal disturbances or
interruption to the achieved high coverage. The Sri Lanka EPI has
consistently shown a high performance and has also continued to
maintain high coverage of all EPI antigens. The country also has one
of the best performing adverse events following immunization
(AEFI) surveillance programs. All of these factors create a very
conducive environment for new vaccine introduction.
Introduction of Hib vaccine to the national immunization
schedule will directly reduce 50% of the bacterial meningitis
disease burden. In addition to this, Hib vaccination has been shown
to indirectly reduce disease burden due to pneumonia by 20%; this
effect was well demonstrated by the Gambian vaccine trial.16 The
conjugate Hib vaccine available in the private sector is beyond the
ﬁnancial reach of the poorer segments of the populationwho are at
higher risk of the infection, which is an issue of social equity in
access to a life saving preventive measure.
Sri Lanka introduced theHib vaccine in the pentavalent form in
January 2008. Prior to this study therewere noHib disease burden
data fromSri Lanka. This is the ﬁrst study reporting incidence from
Sri Lanka and one of the few from the Asian region. The study
results were used in the decision-making process and in the
application to GAVI (The Global Alliance for Vaccines and
Immunisation) for the introduction of the Hib vaccine. Hib
vaccine introduction to the national immunization program will
ensure continued provision of a high quality EPI service in Sri
Lanka in the tradition of a free health service, maintaining social
justice.
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